SEQENS is a custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. A cGMP contract manufacturing organization (CMO), PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules for clinical trials and APIs used in generic pharmaceuticals. With its two facilities, PCI produces products from grams to multi tons all within one organization. To learn more about PCI Synthesis, its proprietary NCE development activities and manufacturing capabilities please visit www.seqens.com.